| Product Code: ETC8551503 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, the Netherlands saw a continued high concentration of viral vector import shipments, with Belgium, Hungary, USA, Japan, and Sweden emerging as the top exporting countries. Despite a slight decline in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) from 2020 to 2024 stood at a steady 3.85%. This data highlights the significance of these key exporting nations in supplying viral vectors to meet the demand in the Netherlands, indicating a stable market for viral vector imports in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Viral Vector Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Viral Vector Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Viral Vector Market - Industry Life Cycle |
3.4 Netherlands Viral Vector Market - Porter's Five Forces |
3.5 Netherlands Viral Vector Market Revenues & Volume Share, By Vector Type, 2021 & 2031F |
3.6 Netherlands Viral Vector Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Netherlands Viral Vector Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Netherlands Viral Vector Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investments in biotechnology and pharmaceutical industries in the Netherlands |
4.2.2 Growing prevalence of genetic disorders and infectious diseases driving the demand for viral vector-based therapies |
4.2.3 Technological advancements in viral vector production and gene therapy research |
4.3 Market Restraints |
4.3.1 Stringent regulations and guidelines for viral vector research and development |
4.3.2 High costs associated with viral vector production and gene therapy development |
5 Netherlands Viral Vector Market Trends |
6 Netherlands Viral Vector Market, By Types |
6.1 Netherlands Viral Vector Market, By Vector Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Viral Vector Market Revenues & Volume, By Vector Type, 2021- 2031F |
6.1.3 Netherlands Viral Vector Market Revenues & Volume, By Adeno-associated Virus (AAV), 2021- 2031F |
6.1.4 Netherlands Viral Vector Market Revenues & Volume, By Adenovirus, 2021- 2031F |
6.1.5 Netherlands Viral Vector Market Revenues & Volume, By Lentivirus, 2021- 2031F |
6.1.6 Netherlands Viral Vector Market Revenues & Volume, By Retrovirus, 2021- 2031F |
6.1.7 Netherlands Viral Vector Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Netherlands Viral Vector Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Viral Vector Market Revenues & Volume, By Cell & Gene Therapy, 2021- 2031F |
6.2.3 Netherlands Viral Vector Market Revenues & Volume, By Vaccine, 2021- 2031F |
6.2.4 Netherlands Viral Vector Market Revenues & Volume, By Biopharmaceutical & Pharmaceutical Discovery, 2021- 2031F |
6.3 Netherlands Viral Vector Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Viral Vector Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.3.3 Netherlands Viral Vector Market Revenues & Volume, By Academics & Research Institutes, 2021- 2031F |
6.3.4 Netherlands Viral Vector Market Revenues & Volume, By CROs & CMOs, 2021- 2031F |
7 Netherlands Viral Vector Market Import-Export Trade Statistics |
7.1 Netherlands Viral Vector Market Export to Major Countries |
7.2 Netherlands Viral Vector Market Imports from Major Countries |
8 Netherlands Viral Vector Market Key Performance Indicators |
8.1 Number of clinical trials utilizing viral vectors in the Netherlands |
8.2 Research and development spending in gene therapy and viral vector technologies |
8.3 Number of partnerships and collaborations between academic institutions, biotech companies, and pharmaceutical firms in the viral vector market in the Netherlands |
9 Netherlands Viral Vector Market - Opportunity Assessment |
9.1 Netherlands Viral Vector Market Opportunity Assessment, By Vector Type, 2021 & 2031F |
9.2 Netherlands Viral Vector Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Netherlands Viral Vector Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Netherlands Viral Vector Market - Competitive Landscape |
10.1 Netherlands Viral Vector Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Viral Vector Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here